Literature DB >> 16769274

The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma.

Yoshito Tomimaru1, Yo Sasaki, Terumasa Yamada, Hidetoshi Eguchi, Koji Takami, Hiroaki Ohigashi, Masahiko Higashiyama, Osamu Ishikawa, Ken Kodama, Shingi Imaoka.   

Abstract

BACKGROUND: Pulmonary metastasis, which is the most common type of extrahepatic recurrence of hepatocellular carcinoma (HCC), has been considered unsuitable for surgical resection because most pulmonary metastases are multiple. Until now there have been few reports about surgical resection for pulmonary metastasis from HCC. The aim of the present study was to evaluate the significance of surgical resection for pulmonary metastasis from HCC.
METHODS: Among 615 patients who underwent radical hepatic resection for HCC in our hospital over the past 15 years, 8 patients who had developed 1 or 2 pulmonary metastases underwent pulmonary resection for the pulmonary metastases (resection group), the other 6 patients who had developed 1 or 2 pulmonary metastases did not undergo pulmonary resection (nonresection group). The clinicopathologic features and long-term prognosis of the resection group were examined and compared with those of the nonresection group.
RESULTS: In the resection group, although intrahepatic recurrences were present before the diagnosis of pulmonary metastasis in 4 patients, they were well controlled by repeated transarterial chemoembolization and/or further hepatic resections. The average survival periods after the pulmonary resection and after the initial hepatic resection were 29 months (range, 5-80 mo) and 61 months (range, 24-133 mo), respectively. No patients in the resection group showed pulmonary recurrence after the pulmonary resection, and the cause of death of the patients in the resection group was not pulmonary metastasis. The survival rate of patients in the resection group was significantly better than that in the nonresection group.
CONCLUSIONS: It may be concluded that surgical resection for pulmonary metastasis from HCC might be beneficial in selected patients.

Entities:  

Mesh:

Year:  2006        PMID: 16769274     DOI: 10.1016/j.amjsurg.2005.12.006

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  41 in total

1.  Risk factors, clinical features, and prognosis of the hepatocellular carcinoma with peritoneal metastasis.

Authors:  Min-Sun Kwak; Jeong-Hoon Lee; Jung-Hwan Yoon; Su Jong Yu; Eun Ju Cho; Eun Sun Jang; Yoon Jun Kim; Hyo-Suk Lee
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

2.  Factors linked to longterm survival of patients with hepatocellular carcinoma accompanied by tumour thrombus in the major portal vein after surgical resection.

Authors:  Rumi Matono; Shohei Yoshiya; Takashi Motomura; Takeo Toshima; Hiroto Kayashima; Toshiro Masuda; Tomoharu Yoshizumi; Akinobu Taketomi; Ken Shirabe; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-02-03       Impact factor: 3.647

3.  Long-term interferon-α treatment suppresses tumor growth but promotes metastasis capacity in hepatocellular carcinoma.

Authors:  Peng-Yuan Zhuang; Ju-Bo Zhang; Wei Zhang; Xiao-Dong Zhu; Ying Liang; Hua-Xiang Xu; Yu-Quan Xiong; Ling-Qun Kong; Lu Wang; Wei-Zhong Wu; Zhao-You Tang; Lun-Xiu Qin; Hui-Chuan Sun
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-06       Impact factor: 4.553

4.  Three risk factors for pulmonary metastasectomy in patients with hepatocellular carcinoma.

Authors:  Akifumi Nakamura; Minoru Esaki; Kazuo Nakagawa; Keisuke Asakura; Yoji Kishi; Satoshi Nara; Kazuaki Shimada; Shun-Ichi Watanabe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-02-28

5.  Gallbladder metastasis from hepatocellular carcinoma: Report of a case and review of literature.

Authors:  Masaki Wakasugi; Shigeyuki Ueshima; Hiroki Akamatsu; Masayuki Tori; Masahide Oshita; Masahiko Tsujimoto; Toshirou Nishida
Journal:  Int J Surg Case Rep       Date:  2012-06-01

Review 6.  Progress in the treatment of pulmonary metastases after liver transplantation for hepatocellular carcinoma.

Authors:  Zhan-Wang Xiang; Lin Sun; Guo-Hong Li; Rakesh Maharjan; Jin-Hua Huang; Chuan-Xing Li
Journal:  World J Hepatol       Date:  2015-09-18

7.  Prolonged survival of metastatic hepatocellular carcinoma: a case report.

Authors:  Nadiah Zainal; Harissa Husainy Hasbullah
Journal:  J Gastrointest Oncol       Date:  2018-04

8.  Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management.

Authors:  Long Sun; Yong-Song Guan; Wei-Ming Pan; Gui-Bing Chen; Zuo-Ming Luo; Hua Wu
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

9.  Pulmonary resection for metastases from hepatocellular carcinoma.

Authors:  Fengshi Chen; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

10.  Long-term survival in a patient with repeated resections for lung metastasis after hepatectomy for ruptured hepatocellular carcinoma: a case report.

Authors:  Kai-Lun Shih; Yang-Yuan Chen; Tsung-Han Teng; Maw-Soan Soon
Journal:  J Med Case Rep       Date:  2008-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.